Clinical and pathologic features of cognitive-predominant corticobasal degeneration
Open Access
- 7 July 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 95 (1), e35-e45
- https://doi.org/10.1212/wnl.0000000000009734
Abstract
Objective To describe clinical and pathologic characteristics of corticobasal degeneration (CBD) with cognitive predominant problems during the disease course. Methods In a series of autopsy-confirmed cases of CBD, we identified patients with cognitive rather than motor predominant features (CBD-Cog), including 5 patients thought to have Alzheimer disease (AD) and 10 patients thought to have behavioral variant frontotemporal dementia (FTD). We compared clinical and pathologic features of CBD-Cog with those from a series of 31 patients with corticobasal syndrome (CBD-CBS). For pathologic comparisons between CBD-Cog and CBD-CBS, we used semiquantitative scoring of neuronal and glial lesion types in multiple brain regions and quantitative assessments of tau burden from image analysis. Results Five of 15 patients with CBD-Cog never had significant motor problems during their disease course. The most common cognitive abnormalities in CBD-Cog were executive and visuospatial dysfunction. The frequency of language problems did not differ between CBD-Cog and CBD-CBS. Argyrophilic grain disease, which is a medial temporal tauopathy associated with mild cognitive impairment, was more frequent in CBD-Cog. Apathy was also more frequent in CBD-Cog. Tau pathology in CBD-Cog was greater in the temporal and less in perirolandic cortices than in CBD-CBS. Conclusion A subset of patients with CBD has a cognitive predominant syndrome than can be mistaken for AD or FTD. Our findings suggest that distribution of tau cortical pathology (greater in temporal and less in perirolandic cortices) may be the basis of this uncommon clinical variant of CBD.This publication has 42 references indexed in Scilit:
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndromeBrain, 2011
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)Journal of Molecular Neuroscience, 2011
- Clinicopathological correlations in corticobasal degenerationAnnals of Neurology, 2011
- Symmetric corticobasal degeneration (S-CBD)Parkinsonism & Related Disorders, 2010
- J. Clifford Richardson and 50 years of progressive supranuclear palsyNeurology, 2008
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Clinicopathological and imaging correlates of progressive aphasia and apraxia of speechBrain, 2006
- Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteriaJournal of Neural Transmission, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991